These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3607300)

  • 1. [Use of prognostic knowledge in the planning and analysis of randomized therapeutic trials].
    Byar D; Chastang C
    Bull Cancer; 1987; 74(2):177-84. PubMed ID: 3607300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing for cancer clinical trials: selection of prognostic factors.
    Brown BW
    Cancer Treat Rep; 1980; 64(2-3):499-502. PubMed ID: 7407790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative clinical trials].
    Yokoyama M
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):404-12. PubMed ID: 6703720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designs for experiments--parallel comparisons of treatment.
    Lavori PW; Louis TA; Bailar JC; Polansky M
    N Engl J Med; 1983 Nov; 309(21):1291-9. PubMed ID: 6633587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical comparison of random allocation methods in cancer clinical trials.
    Hagino A; Hamada C; Yoshimura I; Ohashi Y; Sakamoto J; Nakazato H
    Control Clin Trials; 2004 Dec; 25(6):572-84. PubMed ID: 15588744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On design considerations and randomization-based inference for community intervention trials.
    Gail MH; Mark SD; Carroll RJ; Green SB; Pee D
    Stat Med; 1996 Jun; 15(11):1069-92. PubMed ID: 8804140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of prognostic factors in cancer clinical trials.
    Simon R
    Cancer Treat Rep; 1984 Jan; 68(1):185-92. PubMed ID: 6362863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment by drawing lots in a therapeutic trial with a balance distribution of prognostic factors: the minimization method].
    Mollié A; Hill C
    Rev Epidemiol Sante Publique; 1988; 36(2):138-43. PubMed ID: 3045921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trials symposium. Highlights in development of randomized clinical trials.
    Forbes JF
    Med J Aust; 1981 Feb; 1(4):159-60. PubMed ID: 6939955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors for randomization and stratification and endpoints for the evaluation of trials.
    Sylvester RJ; Suciu S; Yamanaka H
    Prog Clin Biol Res; 1988; 269():275-87. PubMed ID: 3293065
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic knowledge: interest and methods.
    Chastang C; Auquier A; Gremy F
    Bull Cancer; 1980; 67(4):430-6. PubMed ID: 7013863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient heterogeneity in clinical trials.
    Simon R
    Cancer Treat Rep; 1980; 64(2-3):405-10. PubMed ID: 7407777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodology standards associated with quality reporting in clinical studies in pediatric surgery journals.
    Thakur A; Wang EC; Chiu TT; Chen W; Ko CY; Chang JT; Atkinson JB; Fonkalsrud EW; Grosfeld JL
    J Pediatr Surg; 2001 Aug; 36(8):1160-4. PubMed ID: 11479847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A tentative of guideline for phase III study and its problems in clinical aspect].
    Nakao I
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):395-403. PubMed ID: 6703719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners.
    Geller NL; Pocock SJ
    Biometrics; 1987 Mar; 43(1):213-23. PubMed ID: 3567306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer clinical trials in the USA: patient eligibility, generalizability of results and technology transfer.
    Begg CB
    Bull Cancer; 1987; 74(2):197-203. PubMed ID: 3607303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond classical meta-analysis: can inadequately reported studies be included?
    Robertson C; Idris NR; Boyle P
    Drug Discov Today; 2004 Nov; 9(21):924-31. PubMed ID: 15501727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Randomization for controlled therapeutic trials].
    Schemper M
    Wien Klin Wochenschr; 1982 Nov; 94(22):604-9. PubMed ID: 7164464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Statistical methods in the evaluation of the therapeutic efficacy--their problems and solutions].
    Tominaga S
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1873-81. PubMed ID: 6764094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.